Get the Stockscreener App
78.10
0.21%
0.16
After Hours:
78.34
0.24
+0.31%
Dexcom Inc stock is traded at $78.10, with a volume of 1.96M.
It is up +0.21% in the last 24 hours and up +6.35% over the past month.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
See More
Previous Close:
$77.94
Open:
$78.43
24h Volume:
1.96M
Relative Volume:
0.47
Market Cap:
$31.08B
Revenue:
$3.95B
Net Income/Loss:
$680.80M
P/E Ratio:
85.82
EPS:
0.91
Net Cash Flow:
$535.00M
1W Performance:
+3.80%
1M Performance:
+6.35%
6M Performance:
-38.68%
1Y Performance:
-31.48%
1-Day Range:
$77.18
$78.62
1-Week Range:
$72.51
$79.38
52-Week Range:
$62.34
$142.00
Dexcom Inc Stock (DXCM) Company Profile
Name
Dexcom Inc
Sector
Industry
Phone
(858) 200-0200
Address
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Compare DXCM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
78.10 | 31.08B | 3.95B | 680.80M | 535.00M | 0.91 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-26-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-26-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-30-24 | Initiated | Redburn Atlantic | Neutral |
| Mar-12-24 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-17-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Mar-29-23 | Initiated | UBS | Buy |
| Jan-26-23 | Initiated | Wolfe Research | Outperform |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-15-22 | Initiated | Bernstein | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-03-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-19-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-07-22 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-18-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-28-21 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Jan-06-21 | Upgrade | UBS | Neutral → Buy |
| Oct-02-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| May-27-20 | Reiterated | Piper Sandler | Overweight |
| May-14-20 | Initiated | Wells Fargo | Equal Weight |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Nov-07-19 | Reiterated | Canaccord Genuity | Buy |
| Nov-07-19 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-23-19 | Initiated | Stifel | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Oct-19-18 | Upgrade | Goldman | Sell → Neutral |
| Sep-12-18 | Upgrade | Northland Capital | Under Perform → Market Perform |
| Aug-02-18 | Reiterated | Canaccord Genuity | Buy |
| Jul-02-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-08-18 | Upgrade | JP Morgan | Neutral → Overweight |
| May-11-18 | Initiated | BofA/Merrill | Buy |
| May-03-18 | Reiterated | Canaccord Genuity | Buy |
| Apr-04-18 | Initiated | Goldman | Sell |
| Apr-04-18 | Initiated | Guggenheim | Neutral |
| Mar-23-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-04-18 | Downgrade | Northland Capital | Market Perform → Under Perform |
| Sep-28-17 | Reiterated | Wedbush | Outperform |
View All
Dexcom Inc Stock (DXCM) Latest News
Canada Diabetes Devices Market Forecast Report and Company - GlobeNewswire
Why Is DexCom, Inc. (DXCM) Among the Worst Performing Healthcare Stocks in 2024? - Insider Monkey
Blueshift Asset Management LLC Increases Stock Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Shares Bought by Cynosure Group LLC - MarketBeat
Leerink Partnrs Has Weak Estimate for DexCom FY2025 Earnings - MarketBeat
Swedbank AB Grows Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom Inc. stock rises Tuesday, still underperforms market - MarketWatch
Quantbot Technologies LP Raises Stock Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Why DexCom (DXCM) is a Top Momentum Stock for the Long-Term - Yahoo Finance
DexCom, Inc. (NASDAQ:DXCM) Shares Bought by Qsemble Capital Management LP - MarketBeat
These Are the 5 Worst-Performing Stocks in the Nasdaq-100 With 2024 Almost Over - The Motley Fool
Raymond James Trust N.A. Reduces Stock Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Leerink Partnrs Has Positive Outlook for DexCom Q4 Earnings - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Position Increased by Harvest Fund Management Co. Ltd - MarketBeat
Fisher Asset Management LLC Buys 82,250 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
PNC Financial Services Group Inc. Cuts Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (DXCM): Innovation and Growth Catalysts Amid Strong Long-Term Outlook for Diabetes Care - Insider Monkey
Oura Ring app will soon add blood sugar readings, but it's not as groundbreaking as it sounds - BGR
Australia Diabetes Market Forecasts and Company Analysis 2024-2032, Novo Nordisk, Eli Lilly, Roche, Abbott Laboratories, Insuletn, Dexcom, Medtronic, Ypsomed - Yahoo Finance
BofA reaffirms buy rating on DexCom shares, sees potential for growth - Investing.com Canada
Whetstone Capital Advisors LLC Buys 59,093 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Shares Acquired by Blue Whale Capital LLP - MarketBeat
Type 1 transaction: TSU player's NIL deal with diabetes company - WZTV
Commerce Bank Has $1.27 Million Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Natixis Advisors LLC Has $2.37 Million Stake in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Westfield Capital Management Co. LP Buys 876,739 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Pitcairn Co. Sells 13,769 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Shares Bought by Charles Schwab Investment Management Inc. - MarketBeat
Massachusetts Financial Services Co. MA Sells 1,008,069 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Insider Selling: DexCom, Inc. (NASDAQ:DXCM) EVP Sells $318,275.07 in Stock - MarketBeat
Dexcom's chief HR officer Sadie Stern sells shares worth $318,275 - Investing.com India
B. Metzler seel. Sohn & Co. Holding AG Makes New $1.51 Million Investment in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Eagle Asset Management Inc. Sells 1,026,333 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom Inc. stock underperforms Friday when compared to competitors - MarketWatch
Dexcom's chief HR officer Sadie Stern sells shares worth $318,275 By Investing.com - Investing.com Canada
Here’s Why DexCom (DXCM) Declined In Q3 - Insider Monkey
DexCom and OURA Ink Partnership for Metabolic Health Innovation - Yahoo Finance
Ithaka Group LLC Sells 8,084 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Stock Holdings Lifted by King Luther Capital Management Corp - MarketBeat
Banque Cantonale Vaudoise Has $791,000 Stock Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit - GuruFocus.com
Brown Capital Management LLC Sells 20,521 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Stake Increased by Landscape Capital Management L.L.C. - MarketBeat
Insulet adds Abbott’s FreeStyle Libre 2 Plus to Omnipod 5’s compatibility roster - Medical Device Network
Intech Investment Management LLC Increases Stock Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Thrivent Financial for Lutherans Grows Stock Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom Stock May Gain on Expanded Reach After Stelo's US Launch - MSN
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
Oura Receives $75 Million Series D Investment, Partners With Dexcom to Expand Metabolic Health Offerings - WWD
Dexcom invests $75M in Ōura, agrees to integrate smart rings and CGMs - MedTech Dive
DexCom to invest $75M in smart ring firm ŌURA - MSN
Dexcom Inc Stock (DXCM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Dexcom Inc Stock (DXCM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Sylvain Jereme M | EVP, Chief Financal Officer |
Nov 15 '24 |
Sale |
75.51 |
3,500 |
264,285 |
80,774 |
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):